Demystifying CyberKnife Stereotactic Body Radiation Therapy for Interventional Radiologists

Azzam Khankan; Saif Althaqfi

doi:10.4103/AJIR.AJIR_19_17

The Arab Journal of Interventional Radiology, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · The Arab Journal of Interventional Radiology 2017; 1(02): 55-63
DOI: 10.4103/AJIR.AJIR_19_17

Review Article

Demystifying CyberKnife Stereotactic Body Radiation Therapy for Interventional Radiologists

Autor*innen

Azzam Khankan

Department of Medical Imaging, King Abdulaziz Medical City, Jeddah, Saudi Arabia
Saif Althaqfi

Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia

Abstract

als PDF herunterladen

Stereotactic body radiation therapy (SBRT) using CyberKnife system is a relatively new radiation therapy that has demonstrated feasibility, safety, and efficacy with a high local control of various extracranial unresectable primary cancer and oligometastasis. It involves accurate delivery of very high dose of radiation to the target or tumor volume with high precision and conformity, while minimizing the radiation exposure of nontargeted tissue. Radiopaque fiducial markers (FMs) implantation in and around the tumors is required to track the selected tumor during CyberKnife SBRT, especially in those organs moving with respiration. They act as internal radiographic landmarks that maintain a fixed relationship within the tumor and with each other. Although their implantation can be technically demanding, it can be performed using various techniques with varying success; however, percutaneous implantation under image guidance by interventional radiologists is the most common method. Close collaboration between interventional radiologists and radiation oncologists with understanding of the technical aspects of CyberKnife SBRT and FMs implantation has important implications for optimal delivery of therapy and direct impact on the interventional radiology practice in selected patients proposed for CyberKnife SBRT.

CyberKnife - fiducial marker - stereotactic body radiation therapy

PDF (1109 kb)

Referenzen

References
1 Kirkbride P, Cooper T. Stereotactic body radiotherapy. Guidelines for commissioners, providers and clinicians: A national report. Clin Oncol (R Coll Radiol) 2011;23:163-4.
2 Martin A, Gaya A. Stereotactic body radiotherapy: A review. Clin Oncol (R Coll Radiol) 2010;22:157-72.
3 Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316-9.
4 Blomgren H, Lax I, Näslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-70.
5 Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677-83.
6 Hanna GG, Landau D. Stereotactic body radiotherapy for oligometastatic disease. Clin Oncol (R Coll Radiol) 2015;27:290-7.
7 Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-8.
8 Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials. Lancet Oncol 2015;16:630-7.
9 Franks KN, Jain P, Snee MP. Stereotactic ablative body radiotherapy for lung cancer. Clin Oncol (R Coll Radiol) 2015;27:280-9.
10 Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int 2012;110(11 Pt B):E737-43.
11 Loblaw A, Cheung P, D'Alimonte L, Deabreu A, Mamedov A, Zhang L, et al. Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes. Radiother Oncol 2013;107:153-8.
12 Henderson DR, Tree AC, van As NJ. Stereotactic body radiotherapy for prostate cancer. Clin Oncol (R Coll Radiol) 2015;27:270-9.
13 Chang BK, Timmerman RD. Stereotactic body radiation therapy: A comprehensive review. Am J Clin Oncol 2007;30:637-44.
14 Ohara K, Okumura T, Akisada M, Inada T, Mori T, Yokota H, et al. Irradiation synchronized with respiration gate. Int J Radiat Oncol Biol Phys 1989;17:853-7.
15 Barnes EA, Murray BR, Robinson DM, Underwood LJ, Hanson J, Roa WH. Dosimetric evaluation of lung tumor immobilization using breath hold at deep inspiration. Int J Radiat Oncol Biol Phys 2001;50:1091-8.
16 Kubo HD, Hill BC. Respiration gated radiotherapy treatment: A technical study. Phys Med Biol 1996;41:83-91.
17 Davies SC, Hill AL, Holmes RB, Halliwell M, Jackson PC. Ultrasound quantitation of respiratory organ motion in the upper abdomen. Br J Radiol 1994;67:1096-102.
18 Bryan PJ, Custar S, Haaga JR, Balsara V. Respiratory movement of the pancreas: An ultrasonic study. J Ultrasound Med 1984;3:317-20.
19 Wong JW, Sharpe MB, Jaffray DA, Kini VR, Robertson JM, Stromberg JS, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 1999;44:911-9.
20 Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, et al. Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 2014;190:26-33.
21 Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: The report of AAPM Task Group 101. Med Phys 2010;37:4078-101.
22 Potters L, Gaspar LE, Kavanagh B, Galvin JM, Hartford AC, Hevezi JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys 2010;76:319-25.
23 Sahgal A, Roberge D, Schellenberg D, Purdie TG, Swaminath A, Pantarotto J, et al. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin Oncol (R Coll Radiol) 2012;24:629-39.
24 Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, et al. New horizons in tumor microenvironment biology: Challenges and opportunities. BMC Med 2015;13:45.
25 Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005;8:89-91.
26 Kim MS, Kim W, Park IH, Kim HJ, Lee E, Jung JH, et al. Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery. Radiat Oncol J 2015;33:265-75.
27 Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. Radiation-induced vascular damage in tumors: Implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 2012;177:311-27.
28 Macià I Garau M. Radiobiology of stereotactic body radiation therapy (SBRT). Rep Pract Oncol Radiother 2017;22:86-95.
29 Kirkpatrick JP, Kelsey CR, Palta M, Cabrera AR, Salama JK, Patel P, et al. Stereotactic body radiotherapy: A critical review for nonradiation oncologists. Cancer 2014;120:942-54.
30 Kothary N, Dieterich S, Louie JD, Koong AC, Hofmann LV, Sze DY. A primer on image-guided radiation therapy for the interventional radiologist. J Vasc Interv Radiol 2009;20:859-62.
31 Foote M, Bailey M, Smith L, Siva S, Hegi-Johnson F, Seeley A, et al. Guidelines for safe practice of stereotactic body (ablative) radiation therapy. J Med Imaging Radiat Oncol 2015;59:646-53.
32 Valentine K, Cabrera T, Roberge D. Implanting metal fiducials to guide stereotactic liver radiation: McGill experience and review of current devices, techniques and complications. Technol Cancer Res Treat 2014;13:253-8.
33 Sotiropoulou E, Stathochristopoulou I, Stathopoulos K, Verigos K, Salvaras N, Thanos L. CT-guided fiducial placement for cyberknife stereotactic radiosurgery: An initial experience. Cardiovasc Intervent Radiol 2010;33:586-9.
34 Kim JH, Hong SS, Kim JH, Park HJ, Chang YW, Chang AR, et al. Safety and efficacy of ultrasound-guided fiducial marker implantation for CyberKnife radiation therapy. Korean J Radiol 2012;13:307-13.
35 Kothary N, Heit JJ, Louie JD, Kuo WT, Loo BW Jr., Koong A, et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol 2009;20:235-9.
36 Anantham D, Feller-Kopman D, Shanmugham LN, Berman SM, DeCamp MM, Gangadharan SP, et al. Electromagnetic navigation bronchoscopy-guided fiducial placement for robotic stereotactic radiosurgery of lung tumors: A feasibility study. Chest 2007;132:930-5.
37 Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc 2010;71:513-8.
38 Young S, Vogel J, Wiley S, Caridi J. Transarterial fiducial marker placement: A novel technique. J Vasc Interv Radiol 2013;24:756-8.
39 Karaman K, Dokdok AM, Karadeniz O, Ceylan C, Engin K. Intravascular placement of metallic coils as lung tumor markers for cyberknife stereotactic radiation therapy. Korean J Radiol 2015;16:626-31.
40 Prévost JB, Nuyttens JJ, Hoogeman MS, Pöll JJ, van Dijk LC, Pattynama PM. Endovascular coils as lung tumour markers in real-time tumour tracking stereotactic radiotherapy: Preliminary results. Eur Radiol 2008;18:1569-76.
41 Hong JC, Yu Y, Rao AK, Dieterich S, Maxim PG, Le QT, et al. High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors. Int J Radiat Oncol Biol Phys 2011;81:85-90.
42 Trumm CG, Häussler SM, Muacevic A, Stahl R, Stintzing S, Paprottka PM, et al. CT fluoroscopy-guided percutaneous fiducial marker placement for CyberKnife stereotactic radiosurgery: Technical results and complications in 222 consecutive procedures. J Vasc Interv Radiol 2014;25:760-8.
43 Cardella JF, Bakal CW, Bertino RE, Burke DR, Drooz A, Haskal Z, et al. Quality improvement guidelines for image-guided percutaneous biopsy in adults. J Vasc Interv Radiol 2003;14(9 Pt 2):S227-30.
44 Patel A, Khalsa B, Lord B, Sandrasegaran K, Lall C. Planting the seeds of success: CT-guided gold seed fiducial marker placement to guide robotic radiosurgery. J Med Imaging Radiat Oncol 2013;57:207-11.
45 Worm ES, Bertholet J, Høyer M, Fledelius W, Hansen AT, Larsen LP, et al. Fiducial marker guided stereotactic liver radiotherapy: Is a time delay between marker implantation and planning CT needed? Radiother Oncol 2016;121:75-8.
46 Shirato H, Harada T, Harabayashi T, Hida K, Endo H, Kitamura K, et al. Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:240-7.
47 Ohta K, Shimohira M, Iwata H, Hashizume T, Ogino H, Miyakawa A, et al. Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: An initial experience. J Radiat Res 2013;54:957-61.
48 Ngwa W, Boateng F, Kumar R, Irvine DJ, Formenti S, Ngoma T, et al. Smart radiation therapy biomaterials. Int J Radiat Oncol Biol Phys 2017;97:624-37.
49 Cormack RA, Sridhar S, Suh WW, D'Amico AV, Makrigiorgos GM. Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices. Int J Radiat Oncol Biol Phys 2010;76:615-23.
50 Ouyang Z, Mainali MK, Sinha N, Strack G, Altundal Y, Hao Y, et al. Potential of using cerium oxide nanoparticles for protecting healthy tissue during accelerated partial breast irradiation (APBI). Phys Med 2016;32:631-5.